Buchumschlag

Testosterone nadir and clinical outcomes in patients with advanced prostate cancer: Post hoc analysis of triptorelin pamoate Phase III studies

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Laurence Klotz, Tri Tat
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	BJUI Compass
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Real‐world clinical outcomes of oligometastatic prostate cancer using SBRT: An Australian experience
von: Samantha Shekar, et al.
Veröffentlicht: (2025)

Does total lesion prostate‐specific membrane antigen (PSMA) activity on 68Ga‐PSMA PET/CT correlate with PSA and prostatectomy histopathological/clinical outcomes in patients with localised primary prostate cancer?
von: Jeremy Cheng, et al.
Veröffentlicht: (2025)

Focal therapy in prostate cancer: Development, application and outcomes in the United Kingdom
von: Nadia Rokan, et al.
Veröffentlicht: (2025)

Utility of dynamic contrast enhancement for clinically significant prostate cancer detection
von: Eric V. Li, et al.
Veröffentlicht: (2024)

‘It Just Makes Sense to Me’: A qualitative study exploring patient decision‐making and experiences with prostate MRI during active surveillance for prostate cancer
von: Ryan Sutherland, et al.
Veröffentlicht: (2024)

Variation in harms and benefits of prostate‐specific antigen screening for prostate cancer by socio‐clinical risk factors: A rapid review
von: Abel Tesfai, et al.
Veröffentlicht: (2024)

Bibliometric analysis of focal therapy in prostate cancer research
von: Mohammed Shahait, et al.
Veröffentlicht: (2024)

AI‐enhanced micro‐ultrasound improves detection of clinically significant prostate cancer at biopsy
von: Muhammad Imran, et al.
Veröffentlicht: (2026)

MRI performance to identify clinically significant prostate cancer following focal cryo‐ablation
von: Herbert Lepor, et al.
Veröffentlicht: (2025)

Primary urethral cancer: Treatment patterns, responses and survival in localized, advanced and metastatic patients
von: Ilfad Blazevic, et al.
Veröffentlicht: (2025)

Comparing outcomes of Aquablation versus holmium laser enucleation of prostate in the treatment of benign prostatic hyperplasia: A network meta‐analysis
von: Ansh Bhatia, et al.
Veröffentlicht: (2024)

Increased risk of bleeding during and after HoLEP in patients with prostate cancer: A multicentre comparative cohort study
von: Angelo Porreca, et al.
Veröffentlicht: (2025)

The impact of pre‐biopsy MRI and additional testing on prostate cancer screening outcomes: A rapid review
von: Abel Tesfai, et al.
Veröffentlicht: (2024)

Oncological outcomes post focal low‐dose‐rate brachytherapy in low‐intermediate risk prostate cancer
von: Mohammadmehdi Adhami, et al.
Veröffentlicht: (2026)

A machine learning algorithm for automatic tumour board recommendations in prostate cancer patients
von: Marcus Sondermann, et al.
Veröffentlicht: (2025)

Does bladder outflow obstruction obfuscate the traditional clinical factors that are used to assess the risk of prostate cancer at rapid‐access diagnostic clinics?
von: Thomas Philip Cahill, et al.
Veröffentlicht: (2024)

Genomic prostate score and treatment selection in favourable intermediate‐risk prostate cancer
von: Eric Margolis, et al.
Veröffentlicht: (2025)

Urinary microbiota diversity and composition in patients with advanced renal cell cancer
von: Frederico Leal, et al.
Veröffentlicht: (2026)

The significant costs of prostate cancer management—An analysis from a Caribbean hospital
von: Geneva Pantoja, et al.
Veröffentlicht: (2025)

Omission of contralateral biopsies in unilateral MRI‐suspicious prostate cancer has minimal impact on clinical risk assessment
von: Stijn M. van den Bosch, et al.
Veröffentlicht: (2026)

Exploring patient and clinician opinions, perspectives and acceptance of the use of artificial intelligence in the histological diagnosis of prostate cancer
von: Lisa Browning, et al.
Veröffentlicht: (2025)

Emerging tools for the early detection of prostate cancer
von: Muhammad Haider, et al.
Veröffentlicht: (2025)

Quality of English‐ and Spanish‐language online content about prostate cancer genetics: Insights into potential contributors to prostate cancer disparities
von: Sophia M. Abusamra, et al.
Veröffentlicht: (2025)

Impact of multiparametric MRI and prostate biopsies on anxiety and quality of life in men with suspected prostate cancer
von: Esther H. J. Hamoen, et al.
Veröffentlicht: (2025)

Extended versus limited pelvic lymph node dissection and long‐term outcomes in high‐risk prostate cancer before radiotherapy
von: Georgios Daouacher, et al.
Veröffentlicht: (2026)

A pilot study evaluating the safety and efficacy of En‐bloc holmium laser enucleation of the prostate in patients with a history of radiation therapy or high intensity focused ultrasound for management of organ confined prostate cancer with review of the literature
von: Renil S. Titus, et al.
Veröffentlicht: (2025)

A multicentre retrospective analysis of anterior urethroplasty techniques and outcomes for urethral stricture disease secondary to transurethral resection of the prostate
von: Łukasz Białek, et al.
Veröffentlicht: (2026)

Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
von: Arjun Pon Avudaiappan, et al.
Veröffentlicht: (2024)

Micro‐ultrasound tissue echogenicity predicts prostate cancer grade
von: Ailene E. Corona, et al.
Veröffentlicht: (2026)

Targeted Prostate Health Checks, a novel system to identify men with prostate cancer—A pilot study
von: Stephen Langley, et al.
Veröffentlicht: (2024)

Investigating the prognostic utility of GSTP1 promoter methylation in prostate cancer
von: Ruth Pidsley, et al.
Veröffentlicht: (2024)

National survey of urologists' views on prostate cancer screening in the United Kingdom
von: Nikhil Mayor, et al.
Veröffentlicht: (2026)

Racial and socioeconomic disparities in surgical care for post‐prostate cancer treatment complications: A nationwide Medicare‐based analysis
von: Oluwafolajimi Adesanya, et al.
Veröffentlicht: (2024)

Incorporating the NICE Cambridge Prognostic Groups and Predict Prostate into a structured informed‐decision making clinic reduces over‐treatment rates of early prostate cancer
von: Vincent J. Gnanapragasam, et al.
Veröffentlicht: (2025)

PARP inhibitor‐based treatment in metastatic, castration‐resistant prostate cancer (mCRPC): A systematic review and meta‐analysis
von: Michela Roberto, et al.
Veröffentlicht: (2025)

Cost‐effectiveness analysis of a biopsy‐free diagnostic strategy for prostate cancer using mpMRI and PSMA‐PET/CT
von: Joshua Yi Min Tung, et al.
Veröffentlicht: (2026)

Impact of recreational football in men with prostate cancer undergoing androgen deprivation therapy
von: Sofia Mesquita, et al.
Veröffentlicht: (2025)

Anatomical distribution of disease in pN1 prostate cancer with BCR post‐RP: A PSMA‐PET/CT‐based analysis
von: Lotte G. Zuur, et al.
Veröffentlicht: (2025)

A systematic review of the patient reported outcomes that affect patients with muscle invasive bladder cancer after radical cystectomy and urinary diversion
von: John Lahoud, et al.
Veröffentlicht: (2024)

Analysis of urinary volatile organic compounds for prostate cancer diagnosis: A systematic review
von: Jonathon Dawson, et al.
Veröffentlicht: (2024)